7Baggers
 Alnylam Pulls TV Ad After FDA Crackdown on Drug Commercials  Bloomberg.com Thu, 02 Oct 2025 20:28:33 GMT
 Alnylam Pharmaceuticals (ALNY) Pulls Ad After FDA Warning  GuruFocus Thu, 02 Oct 2025 20:03:46 GMT
 Alnylam pulls heart drug TV ad amid FDA crackdown  Investing.com Thu, 02 Oct 2025 14:53:57 GMT
 alnylam pulls tv ad after trump crackdown on drug industry spots  Bloomberg.com Thu, 02 Oct 2025 14:24:57 GMT
 Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?  Yahoo Finance Wed, 01 Oct 2025 15:05:00 GMT
 Alnylam (ALNY) Begins Phase 3 Trial for Hypertension Drug Zilebe  GuruFocus Wed, 01 Oct 2025 12:21:32 GMT
 alnylam doses first patient in zenith trial  TipRanks Wed, 01 Oct 2025 11:55:11 GMT
 u.s. porphyria treatment market set to witness massive growth  openPR.com Wed, 01 Oct 2025 07:25:27 GMT
 Alnylam Joins Genomic Alliance To Boost RNAi Drug Discovery  Technology Networks Tue, 30 Sep 2025 18:42:27 GMT
 u.s. transthyretin amyloidosis treatment market to witness  openPR.com Tue, 30 Sep 2025 13:31:01 GMT
 Alnylam and Ionis Pharmaceuticals are the leading companies  openPR.com Tue, 30 Sep 2025 12:16:10 GMT
 is alnylam pharmaceuticals (nasdaq:alny) using debt in a risky way?  Yahoo Finance Mon, 29 Sep 2025 14:02:34 GMT
 vutrisiran treatment reduces gi events in attr-cm patients by up to 49%  Investing.com Nigeria Mon, 29 Sep 2025 06:02:50 GMT
 vutrisiran treatment reduces gi events in attr-cm patients by up to 49%  Investing.com South Africa Sun, 28 Sep 2025 21:22:06 GMT
 rna-based therapies industry analysis 2025 | growth, usa market  openPR.com Fri, 26 Sep 2025 11:48:58 GMT
 is alnylam pharmaceuticals (alny) an undervalued stock?  Yahoo Thu, 25 Sep 2025 13:53:50 GMT
 Alnylam Joins Illumina and NashBio for Faster, More Inclusive Drug Discovery  Inside Precision Medicine Thu, 25 Sep 2025 13:50:56 GMT
 huntington's disease pipeline 2025: innovative clinical  openPR.com Wed, 24 Sep 2025 22:38:03 GMT
 alnylam at bernstein forum: strategic growth in rnai therapies  Investing.com Tue, 23 Sep 2025 13:34:22 GMT
 alnylam pharma executes note repurchase transactions  MSN Mon, 22 Sep 2025 19:31:46 GMT
 with dtc ads under fire, pharma companies need to pivot  PharmaVoice Mon, 22 Sep 2025 11:17:02 GMT
 alnylam price target raised to $500 from $435 at rbc capital  TipRanks Fri, 19 Sep 2025 16:04:16 GMT
 rbc capital raises alnylam pharmaceuticals (alny) price target t  GuruFocus Fri, 19 Sep 2025 14:07:16 GMT
 moderna (mrna) settles patent dispute with alnylam  GuruFocus Fri, 19 Sep 2025 12:18:00 GMT
 alnylam stock price target raised to $500 from $435 at rbc capital  Investing.com Fri, 19 Sep 2025 09:55:00 GMT
 alnylam pharmaceuticals, inc. $alny shares bought by swedbank ab  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 alnylam pharmaceuticals, inc. $alny shares acquired by swedbank ab  MarketBeat Fri, 19 Sep 2025 05:24:13 GMT
 moderna, alnylam agree to end vaccine-delivery patent lawsuits  Bloomberg Law News Fri, 19 Sep 2025 00:25:00 GMT
 alnylam joins genomic alliance to advance rna interference therapies  Investing.com Thu, 18 Sep 2025 14:42:29 GMT
 editor’s pick: city therapeutics  Nature Thu, 18 Sep 2025 10:16:54 GMT
 alnylam jumps on full year revenue guidance raise  MSN Mon, 15 Sep 2025 10:16:23 GMT
 Assessing Alnylam After Stock Surges 100% on RNAi Momentum in 2025  simplywall.st Sat, 13 Sep 2025 07:00:00 GMT
 alnylam pharma executes note repurchase transactions  TipRanks Fri, 12 Sep 2025 21:58:23 GMT
 top pharmaceutical stocks to follow today - september 10th  MarketBeat Thu, 11 Sep 2025 19:45:28 GMT
 pharmaceutical stocks to add to your watchlist - september 9th  MarketBeat Wed, 10 Sep 2025 19:44:48 GMT
 alnylam at morgan stanley healthcare: strategic growth and challenges  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 alnylam pharma announces $500m convertible notes offering  TipRanks Wed, 10 Sep 2025 07:00:00 GMT

Alnylam Pharmaceuticals, Inc
(NASDAQ:ALNY) 

ALNY stock logo

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, an...

Founded: 2002
Full Time Employees: 1,323
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends